Welcure Q1FY26 Profit Jumps 830% on asset-light export model
Welcure Drugs and Pharmaceuticals Ltd reported ₹23.29 crore net profit in Q1FY26, up 830% Q-o-Q. Revenue surged 1300% to ₹299.91 crore due to its fee-based sourcing model. A ₹517 crore mandate may add ₹25.85 crore in FY26. EPS stood at ₹2.07. Strategic board appointments and export focus are positioning the company for long-term growth.